https://www.fortunebusinessinsights.com/molecular-imaging-market-112879
https://www.fortunebusinessinsights.com/molecular-imaging-market-112879
The global molecular imaging market was valued at USD 2.19 billion in 2024 and is expected to grow to
USD 2.32 billion in 2025, reaching USD 3.46 billion by 2032. This reflects a compound annual growth rate
(CAGR) of 5.9% during the forecast period. In 2024, North America held the largest share of the molecular
imaging market, accounting for 63.83% of the total market.
The molecular imaging market is experiencing steady growth as demand increases for accurate, non-
invasive diagnostic tools across various medical fields, including oncology, cardiology, and neurology. This
advanced imaging approach enables real-time visualization of biological processes at the molecular and
cellular levels, enhancing early disease detection and personalized treatment planning. Technological
innovations, along with rising investment in healthcare infrastructure and research, are supporting
broader adoption. As awareness of precision medicine continues to grow, the molecular imaging market
is expected to expand further in both developed and emerging regions.
Continue reading for more details:
https://www.fortunebusinessinsights.com/molecular-imaging-market-112879
Market Segmentation
• The molecular imaging market is segmented by technology into PET, SPECT, and multimodal
imaging systems.
• By application, the molecular imaging market includes oncology, cardiology, neurology, and
inflammatory disorders.
• Segmentation by end user comprises hospitals, diagnostic imaging centers, and research
institutions in the molecular imaging market.
• The molecular imaging market is also categorized by radiotracer type, including FDG,
Technetium-99m, and novel tracers.
• Regional segmentation in the molecular imaging market allows for analysis of growth trends and
adoption patterns across key markets.
List Of Key Molecular Imaging Companies Profiled:
• GE Healthcare (U.S.)
• Siemens Healthineers AG (Germany)
• Koninklijke Philips N.V. (Netherlands)
• Shimadzu Corporation (Japan)
• CANON MEDICAL SYSTEMS CORPORATION (Japan)
• Bruker (U.S.)
• Lantheus Holdings, Inc. (U.S.)
• Segami Corporation (U.S.)
Market Growth
• The molecular imaging market is witnessing steady growth due to increasing demand for non-
invasive and precise diagnostic tools in oncology, cardiology, and neurology.
• Advancements in imaging technologies such as PET, SPECT, and hybrid modalities are propelling
the molecular imaging market forward.
• Growing focus on early disease detection and personalized medicine is significantly driving the
molecular imaging market.
• Rising prevalence of chronic diseases and cancer is boosting the adoption of advanced imaging
techniques within the molecular imaging market.
• The integration of AI and data analytics with imaging platforms is expected to enhance
diagnostic accuracy and further fuel the molecular imaging market.
Restraining Factors
• High cost of molecular imaging equipment and procedures remains a major barrier in the
molecular imaging market.
•
Limited availability of trained professionals and specialized infrastructure hinders broader
adoption in the molecular imaging market.
• Strict regulatory approvals and compliance requirements can delay product development in the
molecular imaging market.
• Reimbursement challenges in some regions reduce patient access and limit market penetration
of the molecular imaging market.
•
Logistical issues related to the short half-life of certain tracers restrict widespread use within the
molecular imaging market.
Regional Analysis
• North America leads the molecular imaging market, supported by advanced healthcare
infrastructure and high R&D investment.
• Europe holds a strong position in the molecular imaging market, driven by government-funded
research initiatives and disease screening programs.
• Asia Pacific is emerging as a fast-growing region in the molecular imaging market, fueled by
expanding diagnostic capabilities and growing healthcare expenditure.
• The Middle East and Africa show gradual growth in the molecular imaging market due to
improving diagnostic imaging access.
•
Latin America is seeing rising adoption in the molecular imaging market, supported by increased
awareness and development of imaging facilities.